GOLDMAN SACHS GROUP INC - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 10 filers reported holding CYCLO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$45,00010,2830.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
XTX Topco Ltd 12,900$18,3180.00%
Virtu Financial LLC 10,732$150.00%
Tower Research Capital LLC (TRC) 6,767$9,6090.00%
JPMORGAN CHASE & CO 240$3410.00%
ROYAL BANK OF CANADA 746$1,0000.00%
VANGUARD GROUP INC 282,027$400,4780.00%
UBS Group AG 88$1250.00%
IFP Advisors, Inc 13$180.00%
OSAIC HOLDINGS, INC. 600$8520.00%
WELLS FARGO & COMPANY/MN 2,352$3,3400.00%
View complete list of CYCLO THERAPEUTICS INC shareholders